Australia markets closed

Runben Biotechnology Co., Ltd. (603193.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
20.65-0.77 (-3.59%)
At close: 03:00PM CST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
240,376
226,027
160,045
120,647
94,712
-
Depreciation & amortisation
-
21,868
19,768
10,531
8,005
-
Change in working capital
-
15,316
-14,885
4,024
-15,364
-
Inventory
-
7,388
-46,947
-14,085
-16,435
-
Other working capital
248,411
238,870
124,671
-13,381
28,930
-
Other non-cash items
-
-13,757
428.6021
294.6352
-
1,789
Net cash provided by operating activities
-
252,521
165,324
138,652
87,135
-
Cash flows from investing activities
Investments in property, plant and equipment
-9,199
-13,651
-40,653
-152,033
-58,205
-
Purchases of investments
-2,019,911
-1,882,110
-432,620
-431,263
-211,533
-
Sales/maturities of investments
568,826
586,077
482,668
419,155
194,757
-
Net cash used for investing activities
-1,460,282
-1,309,682
9,533
-164,137
-74,981
-
Net change in cash
-229,282
-84,321
165,472
163,146
28,408
-
Cash at beginning of period
334,022
368,146
202,674
39,528
11,120
-
Cash at end of period
104,740
283,825
368,146
202,674
39,528
-
Free cash flow
Operating cash flow
-
252,521
165,324
138,652
87,135
-
Capital expenditure
-9,199
-13,651
-40,653
-152,033
-58,205
-
Free cash flow
248,411
238,870
124,671
-13,381
28,930
-